India In-Vitro diagnostic market is anticipated to
witness impressive growth during the forecast period. This can be ascribed due
to increase in IVF technologies, IVF technology has improved significantly in
recent years, with the development of new techniques such as intracytoplasmic
sperm injection (ICSI), preimplantation genetic testing (PGT), and frozen
embryo transfer (FET). These advances have improved the success rates of IVF. Also,
chronic and infectious diseases are on the rise, with an aging population,
changing lifestyle patterns, and rising prevalence of risk factors such as
obesity and smoking. This has led to a growing demand for diagnostic tests to
detect and monitor these diseases, driving the growth of the India in-vitro
diagnostics market. Increase in disposable income and healthcare spending, due
to India's growing middle class and increasing disposable income have led to
greater healthcare spending, including fertility treatments such as IVF. This
has led to the establishment of more IVF centers and increased accessibility of
these treatments. In-vitro diagnostics tests can be used to diagnose, monitor,
and manage diseases and medical conditions, and are an important tool for
healthcare professionals in making informed decisions about patient care. The
Indian government has implemented several policies and programs to support
assisted reproductive technologies, including the National Health Mission and
the National Guidelines for Accreditation, Supervision, and Regulation of
assisted reproductive technology clinics in India. These policies have improved
the availability and affordability of IVF treatments in the country. There is a
growing focus on quality control and regulatory compliance in the India
in-vitro diagnostics market, as healthcare providers seek to ensure the
accuracy and reliability of diagnostic test results.
Improvement in IVF Technologies
In vitro fertilization (IVF) is a medical procedure
used to help couples conceive a child when other fertility treatments have not
been successful. IVF involves fertilizing an egg with sperm outside the body,
in a laboratory dish, and then implanting the fertilized egg into the uterus.
In recent years, there have been several advances in IVF technologies in India.
Pre-implantation genetic testing (PGT) is a technique used to test the embryos
for genetic disorders before they are implanted into the uterus. This
technology helps in selecting healthy embryos for implantation, reducing the
risk of genetic diseases in the offspring. Cryopreservation of eggs and embryos
is a process of freezing and storing eggs and embryos for future use. This
technology has improved the success rates of IVF by allowing couples to store
and use embryos in future IVF cycles. Time-lapse imaging is a technique that
involves taking continuous images of the developing embryos to track their
growth and development. This technology helps embryologists to select the best
embryos for implantation. Intra-Cytoplasmic Sperm Injection (ICSI) is a
technique used to inject a single sperm directly into an egg, which can improve
fertilization rates in cases of male infertility. Natural cycle IVF is a
technique that involves retrieving a single egg during a woman's natural
menstrual cycle, without the use of fertility drugs. This technique has lower
costs and fewer side effects than conventional IVF but is only suitable for
certain women with good fertility potential. These advances in IVF technologies
have led to improved success rates and reduced risks and costs associated with
IVF in India. Additionally, the use of these technologies has made IVF
accessible to a wider range of couples, including those with complex fertility
issues or genetic disorders. This factor is one of the major reasons for the
growth of the India in-vitro diagnostics market.
Increase in Disposable Income and Healthcare
Infrastructure
In-vitro diagnostics tests and procedures can be
expensive, and many people may not be able to afford them. However, as
disposable income increases, more people will be able to pay for these tests
and procedures, which, in turn, will drive the demand for in-vitro diagnostic
products and services. In addition, an increase in disposable income may lead
to a greater emphasis on preventive healthcare, as people may be more willing
to invest in maintaining their health and detecting diseases early. This can
lead to a greater demand for screening and diagnostic tests. The in-vitro
diagnostics market relies heavily on healthcare infrastructure, including
hospitals, clinics, diagnostic laboratories, and imaging centers, to provide
testing services and to access patients for diagnosis and treatment. A
well-developed healthcare infrastructure is essential for the effective delivery
of in-vitro diagnostics services, as it provides the necessary facilities,
equipment, and skilled personnel to carry out diagnostic tests and procedures.
For instance, advanced diagnostic equipment such as molecular testing machines,
mass spectrometers, and imaging technologies are essential for carrying out
accurate and reliable diagnostic tests. A robust healthcare infrastructure can
also help to increase access to in-vitro diagnostics services in remote and
rural areas of the country, where healthcare facilities may be limited.
Healthcare infrastructure can also contribute to the development of the India
in-vitro diagnostics market by providing a conducive environment for research
and development activities. For instance, academic institutions and research
centers can collaborate with the industry to develop new and innovative
in-vitro diagnostic products and technologies. This factor will accelerate the
growth of the India in-vitro diagnostics market during the forecast period.
Increasing Cases of Cancer, Diabetes, And
Cardiovascular Diseases
The prevalence of these diseases is on the rise in
India due to factors such as changing lifestyles, increasing urbanization, and
aging population. According to the World Health Organization (WHO), cancer,
diabetes, and cardiovascular diseases are among the leading causes of death in
India. In-vitro diagnostic tests play a critical role in the diagnosis and
monitoring of these diseases. For instance, in-vitro diagnostic tests can be
used to detect cancer at an early stage, allowing for timely intervention and
treatment. Similarly, in-vitro diagnostic tests can be used to monitor blood
glucose levels in diabetic patients, enabling healthcare providers to adjust
treatment plans as necessary. In the case of cardiovascular diseases, in-vitro
diagnostic tests can help to diagnose and monitor conditions such as high blood
pressure and cholesterol levels, which are risk factors for heart disease. The
growing incidence of these diseases is expected to increase the demand for
in-vitro diagnostic tests in India. The Indian government has also taken
several initiatives to address the growing burden of non-communicable diseases,
including cancer, diabetes, and cardiovascular diseases. For instance, the
National Program for Prevention and Control of Cancer, Diabetes, Cardiovascular
Diseases, and Stroke (NPCDCS) was launched in 2010 to provide universal
screening, diagnosis, and treatment for these diseases. This factor will drive
the growth of the India in-vitro diagnostic market during the forecast period.
Download Free Sample Report
Recent Development
In 2021, Siemens Healthineers India collaborated
with Bengaluru-based startup Dozee to develop an AI-powered solution for remote
patient monitoring. The solution aims to improve patient outcomes and reduce the
burden on healthcare providers.
In 2021, Thermo Fisher Scientific announced the
acquisition of Mesa Biotech, a US-based company that specializes in molecular
diagnostic tests. This acquisition is expected to strengthen Thermo Fisher
Scientific's position in the global in-vitro diagnostics market, including
India.
In 2020, Roche Diagnostics India announced a
collaboration with Cipla to expand the access to COVID-19 testing in India.
Under this collaboration, Roche Diagnostics India supplied the cobas SARS-CoV-2
Test to Cipla, which is distributed to government and private testing centers
across India.
In 2020, TransAsia Bio-Medicals announced a
collaboration with Japanese IVD company Eisai Co. Ltd. to develop and
manufacture diagnostic tests for the Indian market. This collaboration is
expected to strengthen TransAsia’s position in the India in-vitro diagnostics
market during the forecast period.
Market Segmentation
The India in-vitro diagnostics market can be
segmented into by product type, by technology, by application, by end user, and
by region. By product type, the market can be segmented into instruments,
reagents, and software & services. By technology, the market can be
segmented into immunoassay, hematology, clinical chemistry, molecular diagnostics,
microbiology, and others. By application, the market can be segmented into
infectious diseases, diabetes, oncology, cardiology, nephrology, and others. By
end user, the market can be segmented into hospitals & clinics, diagnostic
centers & laboratories, and others. By region, the market can be segmented
into North India, South India, East India, and West India.
Market Players
J Mitra & Co Pvt Ltd., Advatech Healthcare Pvt
Ltd., Tulip Diagnostics PVT. Ltd., Transasia Bio-Medicals Ltd., BD India Pvt
Ltd., Siemens Healthcare Pvt. Ltd., and Bio-Rad Laboratories India Pvt. Ltd.
are some of the market players in the India in-vitro diagnostics market.
|
Attribute
|
Details
|
|
Base Year
|
2023
|
|
Historic Data
|
2019 – 2022
|
|
Estimated Year
|
2024
|
|
Forecast Period
|
2025 – 2029
|
|
Quantitative Units
|
Revenue in USD Million, and CAGR for 2018-2023
and 2024-2029
|
|
Report Coverage
|
Revenue forecast, company share, competitive landscape, growth
factors, and trends
|
|
Segments Covered
|
Product Type
Technology
Application
End User
|
|
Regional scope
|
North India, South India, East India, West India
|
|
Key companies profiled
|
J Mitra & Co Pvt Ltd., Advatech
Healthcare Pvt Ltd., Tulip Diagnostics PVT. Ltd., Transasia Bio-Medicals
Ltd., BD India Pvt Ltd., Siemens Healthcare Pvt. Ltd., Bio-Rad Laboratories
India Pvt. Ltd.
|
|
Customization scope
|
10% free report customization with purchase. Addition or alteration to
country, regional & segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase options to
meet your exact research needs. Explore purchase options
|
|
Delivery Format
|
PDF and Excel through Email (We can also provide the editable version
of the report in PPT/Word format on special request)
|
Report Scope:
In this report, the India in-vitro diagnostics
market has been segmented into the following categories, in addition to the
industry trends which have also been detailed below:
- India In-vitro Diagnostics Market,
By Product Type:
o Instruments
o Reagents
o Software & Services
- India In-vitro Diagnostics Market, By
Technology:
o Immunoassay
o Hematology
o Clinical
Chemistry
o Molecular
Diagnostics
o Microbiology
o Others
- India In-vitro Diagnostics Market,
By Application:
o Infectious
Diseases
o Diabetes
o Oncology
o Cardiology
o Nephrology
o Others
- India In-vitro Diagnostics Market,
By End User:
o Hospitals &
Clinics
o Diagnostic
Centers & Laboratories
o Others
- IndiaIn-vitro Diagnostics Market, By
Region:
o North India
o South India
o East India
o West India
Competitive Landscape
Company Profiles: Detailed analysis of
the major companies present in the India in-vitro diagnostics market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional
market players (up to five).
India in-vitro diagnostics market is an
upcoming report to be released soon. If you wish an early delivery of this
report or want to confirm the date of release, please contact us at [email protected]